BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

196 related articles for article (PubMed ID: 16033857)

  • 1. Low triiodothyronine: a new facet of inflammation in end-stage renal disease.
    Zoccali C; Tripepi G; Cutrupi S; Pizzini P; Mallamaci F
    J Am Soc Nephrol; 2005 Sep; 16(9):2789-95. PubMed ID: 16033857
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Circulating levels of adhesion molecules in chronic kidney disease correlate with the stage of renal disease and with C-reactive protein.
    Vaccaro F; Mulè G; Cottone S; Soresi M; Giannitrapani L; Vadalà A; Sparacino V; Calabrese S; Picone FP; Montalto G; Cerasola G
    Arch Med Res; 2007 Jul; 38(5):534-8. PubMed ID: 17560459
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Subclinical hypothyroidism is linked to micro-inflammation and predicts death in continuous ambulatory peritoneal dialysis.
    Enia G; Panuccio V; Cutrupi S; Pizzini P; Tripepi G; Mallamaci F; Zoccali C
    Nephrol Dial Transplant; 2007 Feb; 22(2):538-44. PubMed ID: 17082213
    [TBL] [Abstract][Full Text] [Related]  

  • 4. On-line hemodiafiltration does not induce inflammatory response in end-stage renal disease patients: results from a multicenter cross-over study.
    Vaslaki LR; Berta K; Major L; Weber V; Weber C; Wojke R; Passlick-Deetjen J; Falkenhagen D
    Artif Organs; 2005 May; 29(5):406-12. PubMed ID: 15854217
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hemodialysis procedure does not affect the levels of sICAM-1 and sVCAM-1 in patients with end stage renal disease.
    Liakopoulos V; Eleftheriadis T; Kyropoulos T; Voliotis G; Potamianos S; Zengos N; Stefanidis I; Heintz B
    Ren Fail; 2005; 27(3):315-21. PubMed ID: 15957549
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical and biochemical implications of low thyroid hormone levels (total and free forms) in euthyroid patients with chronic kidney disease.
    Carrero JJ; Qureshi AR; Axelsson J; Yilmaz MI; Rehnmark S; Witt MR; Bárány P; Heimbürger O; Suliman ME; Alvestrand A; Lindholm B; Stenvinkel P
    J Intern Med; 2007 Dec; 262(6):690-701. PubMed ID: 17908160
    [TBL] [Abstract][Full Text] [Related]  

  • 7. IL-18 is involved in vascular injury in end-stage renal disease patients.
    Porazko T; Kúzniar J; Kusztal M; Kúzniar TJ; Weyde W; Kuriata-Kordek M; Klinger M
    Nephrol Dial Transplant; 2009 Feb; 24(2):589-96. PubMed ID: 18775894
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Is dialysis membrane type responsible for increased circulating adhesion molecules during chronic hemodialysis?
    Mrowka C; Heintz B; Sieberth HG
    Clin Nephrol; 1999 Nov; 52(5):312-21. PubMed ID: 10584995
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Elevated circulating levels of soluble CD-40 ligand in haemodialysis patients with symptomatic coronary heart disease.
    Lim PS; Wu MY; Chien SW; Wu TK; Liu CS; Hu CY; Chang HC; Pai MA
    Nephrology (Carlton); 2008 Dec; 13(8):677-83. PubMed ID: 19019166
    [TBL] [Abstract][Full Text] [Related]  

  • 10. High-flux and low-flux dialysis membranes and levels of intercellular adhesion molecule-1 and vascular cell adhesion molecule-1 in children with chronic kidney failure.
    Sawires HK; Mohamed WA; Schaalan MF
    Iran J Kidney Dis; 2012 Sep; 6(5):366-72. PubMed ID: 22976263
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Relationship between triiodothyronine and proinflammatory cytokines in chronic heart failure.
    Lubrano V; Pingitore A; Carpi A; Iervasi G
    Biomed Pharmacother; 2010 Mar; 64(3):165-9. PubMed ID: 19926244
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Carotid atherosclerosis and endothelial cell adhesion molecules as predictors of long-term outcome in chronic hemodialysis patients.
    Papagianni A; Dovas S; Bantis C; Belechri AM; Kalovoulos M; Dimitriadis C; Efstratiadis G; Alexopoulos E; Memmos D
    Am J Nephrol; 2008; 28(2):265-74. PubMed ID: 17989499
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Low triiodothyronine and cardiomyopathy in patients with end-stage renal disease.
    Zoccali C; Benedetto F; Mallamaci F; Tripepi G; Cutrupi S; Pizzini P; Malatino LS; Bonanno G; Seminara G
    J Hypertens; 2006 Oct; 24(10):2039-46. PubMed ID: 16957565
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Type 2 diabetes in patients with end-stage renal disease is not associated with further increased serum inflammatory parameters.
    Bodlaj G; Berg J; Pichler R; Sailer T; Biesenbach G
    J Nephrol; 2004; 17(1):112-7. PubMed ID: 15151267
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Thyroid function, endothelium, and inflammation in hemodialyzed patients: possible relations?
    Malyszko J; Malyszko JS; Pawlak K; Mysliwiec M
    J Ren Nutr; 2007 Jan; 17(1):30-7. PubMed ID: 17198929
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Serum triiodothyronine level as an indicator of inflammation in patients undergoing dialysis.
    Zeraati AA; Layegh P; Famili Y; Naghibi M; Sharifipour F; Shariati Sarabi Z
    Iran J Kidney Dis; 2011 Jan; 5(1):38-44. PubMed ID: 21189433
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Increased electronegative LDL and decreased antibodies against electronegative LDL levels correlate with inflammatory markers and adhesion molecules in hemodialysed patients.
    Lobo JC; Mafra D; Farage NE; Faulin Tdo E; Abdalla DS; de Nóbrega AC; Torres JP
    Clin Chim Acta; 2011 Sep; 412(19-20):1788-92. PubMed ID: 21676364
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Increased indoleamine 2,3-dioxygenase (IDO) activity and elevated serum levels of tryptophan catabolites in patients with chronic kidney disease: a possible link between chronic inflammation and uraemic symptoms.
    Schefold JC; Zeden JP; Fotopoulou C; von Haehling S; Pschowski R; Hasper D; Volk HD; Schuett C; Reinke P
    Nephrol Dial Transplant; 2009 Jun; 24(6):1901-8. PubMed ID: 19155537
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Systemic and vascular inflammation is elevated in early IgA and type 1 diabetic nephropathies and relates to vascular disease risk factors and renal function.
    Nelson CL; Karschimkus CS; Dragicevic G; Packham DK; Wilson AM; O'Neal D; Becker GJ; Best JD; Jenkins AJ
    Nephrol Dial Transplant; 2005 Nov; 20(11):2420-6. PubMed ID: 16115854
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Serum levels of interleukin 6, C-reactive protein, vascular cell adhesion molecule 1, and monocyte chemotactic protein 1 in relation to insulin resistance and glucose intolerance--the Chennai Urban Rural Epidemiology Study (CURES).
    Deepa R; Velmurugan K; Arvind K; Sivaram P; Sientay C; Uday S; Mohan V
    Metabolism; 2006 Sep; 55(9):1232-8. PubMed ID: 16919544
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.